• Explore /
  • Poster
  • / Examination of the tumor immune microenvironment (TIME) with multispectral immunofluorescence (m-IF): Association of markers with prognosis and bevacizumab (bev) benefit in NRG Oncology/NSABP C-08.

Examination of the tumor immune microenvironment (TIME) with multispectral immunofluorescence (m-IF): Association of markers with prognosis and bevacizumab (bev) benefit in NRG Oncology/NSABP C-08.

Abstract Poster

Authors

null

Katherine L. Pogue-Geile

NSABP/NRG Oncology, Pittsburgh, PA

Katherine L. Pogue-Geile , Marion Joy , Ying Wang , Nan Song , Rim S. Kim , Greg Yothers , Carmen Joseph Allegra , Ashok Srinivasan , Melanie Finnigan , Samuel A. Jacobs , Soonmyung Paik , Jennifer Marie Marie Suga , Judith O. Hopkins , Nicholas J. DiBella , Naoyuki G. Saito , Peter C. Lucas , Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Biologic Correlates

Clinical Trial Registration Number

00096278

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3516)

DOI

10.1200/JCO.2021.39.15_suppl.3516

Abstract #

3516

Abstract Disclosures

Similar Posters

First Author: David Silva Moura

First Author: Susanna Swoboda

First Author: Niki Gavrielatou

First Author: Katie Streicher